The Food and Drug Administration approved on Thursday a gene therapy for severe leukocyte adhesion deficiency type 1 (LAD-1), ...
Huntington Beach, California - March 25, 2026 - PRESSADVANTAGE - Moment of Clarity has released a new educational ...
Despite its enormous global burden, osteoarthritis has no licensed disease-modifying treatments, and available analgesics have moderate efficacy and substantial side-effects.1 The success of ...
Drug Safety Monitoring Board (DSMB) gives Noveome Biotherapeutics a recommendation to continue the Necrotizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results